Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis

被引:0
作者
Margaret Wisłowska
Danuta Jakubicz
Krystyna Stępień
Małgorzata Cicha
机构
[1] Central Clinical Hospital,Department of Rheumatology
[2] Central Clinical Hospital,Central Laboratory Diagnostics
来源
Rheumatology International | 2009年 / 29卷
关键词
Rheumatoid arthritis; Osteoporosis; PINP; Ctx;
D O I
暂无
中图分类号
学科分类号
摘要
Joint inflammation in rheumatoid arthritis (RA) induces local periarticular osteoporosis. Generalised bone mineral density (BMD) decrease concerns approximately 50% of rheumatic patients. Both types of bone mass depletion can issue from cytokine-induced (TNF-α, IL-1, IL-6) osteoclasts’ activation, osteoprotegerin and its ligand’s (RANKL) function disorders, patients’ immobilisation and glucocorticosteroid (GCS) intake, as well as from hormonal alterations in postmenopausal women, predominate among RA individuals. The aim of the study was to compare serum concentrations of marker of bone formation—serum aminoterminal propeptide of type I collagen (PINP), and bone resorption, carboxy (C) terminal telopeptide (Ctx), bone turnover markers in RA and osteoarthritis (OA) patients and in RA groups of different disease activity, different degree of joint damage and the history of GCS intake. A total of 50 RA female patients and 50 women with knee OA were included in the study. Blood for morphology and biochemistry laboratory tests was taken. Joint X-rays to establish OA and RA diagnosis and the degree of RA progression, as well as DEXA BMD measurements were performed. PINP and Ctx concentrations were assessed. In RA patients the number of swollen and painful joints, the duration of morning stiffness, visual analogue scale values and Waaler–Rose’s test activity were recorded. The Disease Activity Index (DAS 28) was counted from the appropriate formula. No differences in bone turnover markers’ concentrations were noted neither between RA and OA patients nor between the RA group when compared to the one without the history of GCS use. Bone turnover markers’ concentrations in RA were proportional to the number of swollen and painful joints. However, no correlation was found between the markers’ concentrations and RA activity assessed by DAS 28 or by laboratory means. Ctx concentrations were higher in patients at II degree joint damage according to Larsen and Dale’s than at more advanced stages. Ctx concentrations decreased with the disease duration. Serum morphogenesis and resorption markers’ concentrations change in course of RA indicating the decrease in bone metabolic activity with the disease duration and progression. High RA activity and severity correlate with increased markers’ levels—the resorption one. The influence of GCS on bone metabolism in RA requires further study.
引用
收藏
页码:1403 / 1409
页数:6
相关论文
共 50 条
[41]   Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate [J].
Cantatore, FP ;
Acquista, CA ;
Pipitone, V .
JOURNAL OF RHEUMATOLOGY, 1999, 26 (11) :2318-2323
[42]   BARICITINIB AND UPADACITINIB AFFECT THE LEVELS OF BONE DESTRUCTION MARKERS AND BONE FORMATION INDICATORS IN PATIENTS WITH RHEUMATOID ARTHRITIS [J].
Felis-Giemza, A. ;
Kurowska, W. ;
Marecka-Kuzdub, M. ;
Kuca-Warnawin, E. ;
Massalska, M. ;
Maslinski, W. .
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :1433-1433
[43]   Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis [J].
G. Wheater ;
V. E. Hogan ;
Y. K. O. Teng ;
J. Tekstra ;
F. P. Lafeber ;
T. W. J. Huizinga ;
J. W. J. Bijlsma ;
R. M. Francis ;
S. P. Tuck ;
H. K. Datta ;
J. M. van Laar .
Osteoporosis International, 2011, 22 :3067-3072
[44]   The relationship between markers of bone remodeling and the risk of bone fracture in patients with rheumatoid arthritis [J].
Akhverdyan, Yu R. ;
Zavodovsky, B., V ;
Polyakova, Yu, V ;
Sivordova, L. E. ;
Papichev, E., V .
YAKUT MEDICAL JOURNAL, 2021, (02) :120-122
[45]   EVALUATION OF BONE TURNOVER IN TYPE-I OSTEOPOROSIS USING BIOCHEMICAL MARKERS SPECIFIC FOR BOTH BONE-FORMATION AND BONE-RESORPTION [J].
EASTELL, R ;
ROBINS, SP ;
COLWELL, T ;
ASSIRI, AMA ;
RIGGS, BL ;
RUSSELL, RGG .
OSTEOPOROSIS INTERNATIONAL, 1993, 3 (05) :255-260
[46]   ACPA TITER IS AN INDEPENDENT DETERMINANT OF SERUM CTX IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS [J].
Adami, G. ;
Orsolini, G. ;
Fassio, A. ;
Bertelle, D. ;
Benini, C. ;
Viapiana, O. ;
Gatti, D. ;
Rossini, M. .
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :1356-1356
[47]   Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis [J].
Bożena Targońska-Stępniak ;
Magdalena Dryglewska ;
Maria Majdan .
Rheumatology International, 2010, 30 :731-737
[48]   Bone turnover markers in serum but not in saliva correlate with bone mineral density [J].
Kerschan-Schindl, Katharina ;
Boschitsch, Ewald ;
Marculescu, Rodrig ;
Gruber, Reinhard ;
Pietschmann, Peter .
SCIENTIFIC REPORTS, 2020, 10 (01)
[49]   Night shift work and serum markers of bone turnover in male shift workers [J].
Martelli, Margherita ;
Salvio, Gianmaria ;
Lazzarini, Raffaella ;
Milinkovic, Marijana ;
Ciarloni, Alessandro ;
Balercia, Giancarlo ;
Santarelli, Lory ;
Bracci, Massimo .
CHRONOBIOLOGY INTERNATIONAL, 2023, :1270-1278
[50]   Bone resorption and inflammat ory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis [J].
Hasegawa, J ;
Nagashima, M ;
Yamamoto, M ;
Nishijima, T ;
Katsumata, S ;
Yoshino, S .
JOURNAL OF RHEUMATOLOGY, 2003, 30 (03) :474-479